Identifying co-occurring substance use disorders in community mental health centres. Tailored approaches are needed

References

• Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, . Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511–8.
   PubMed Web of Science ®Google Scholar
• Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998;33:587–95.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, . Comorbidity of substance use disorders with mood and anxiety disorders: Results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998;23:893–907.
   PubMed Web of Science ®Google Scholar
• Hall W, Teesson M, Lynskey M, Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Well-Being [References]. Addiction 1999;94:1541–50.
   PubMed Web of Science ®Google Scholar
• Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study [References]. Am J Psychiatry 2001;158:1091–8.
   PubMed Web of Science ®Google Scholar
• Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002 [References]. Drug Alcohol Depend 2004;74:223–34.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry 1996;66:17–31.
   PubMed Web of Science ®Google Scholar
• Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions [References]. Arch Gen Psychiatry 2007;64:566–76.
   PubMed Web of Science ®Google Scholar
• Weaver T, Rutter D, Madden P, Ward J, Stimson G, Renton A. Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: Prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol 2001;36:399–406.
   PubMed Web of Science ®Google Scholar
• Flovig JC, Vaaler AE, Morken G. Substance use at admission to an acute psychiatric department [References]. Nord J Psychiatry 2009;63:113–9.
   PubMed Web of Science ®Google Scholar
• Helseth V, Lykke-Enger T, Johnsen J, Waal H. Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nord J Psychiatry 2009;63:72–7.
   PubMed Web of Science ®Google Scholar
• Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998;24:443–55.
   PubMed Web of Science ®Google Scholar
• Magura S. Effectiveness of dual focus mutual aid for co-occurring substance use and mental health disorders: A review and synthesis of the “Double Trouble” in Recovery evaluation. Subst Use Misuse 2008;43:1904–26.
   PubMed Web of Science ®Google Scholar
• Johnson J. Cost-effectiveness of mental health services for persons with a dual diagnosis: A literature review and the CCMHCP. J Subst Abuse Treat 2000;18:119–27.
   PubMed Web of Science ®Google Scholar
• Hoff RA, Rosenheck RA. Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders. Med Care 1998;36:835–43.
   PubMed Web of Science ®Google Scholar
• Ries RK, Comtois KA. Illness severity and treatment services for dually diagnosed severely mentally ill outpatients [References]. Schizophr Bull 1997;23:239–46.
   PubMed Web of Science ®Google Scholar
• Bartels SJ, Teague GB, Drake RE, Clark RE. Substance abuse in schizophrenia: Service utilization and costs. J Nerv Ment Dis 1993;181:227–32.
   PubMed Web of Science ®Google Scholar
• Research Report SINTEF. SAMDATA-Nøkkeltall fra spesialisthelsetjenesten. 2008. In press.
   Google Scholar
• World Health Organization. ICD-10: The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines; 1992.
   Google Scholar
• Wing JK, Beevor AS, Curtis RH, Park SBG, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS)—Research and development. Br J Psychiatry 1998;172:11–8.
   PubMed Web of Science ®Google Scholar
• Wing J, Curtis RH, Beevor A. Health of the Nation Outcome Scales (HoNOS)—Glossary for HoNOS score sheet. Br J Psychiatry 1999;174:432–4.
   PubMed Web of Science ®Google Scholar
• Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57–67.
   PubMed Web of Science ®Google Scholar
• Mueser KT, Drake RE, Clark RE, McHugo GJ, Mercer-McFadden C, Ackerson TH. A toolkit for evaluating substance abuse in persons with severe mental illness. 1995. Cambridge, MA: The Evaluation Center@HSRI.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th, text revision (DSM-IV-TR). Washington: APA; 2000.
   Google Scholar
• Ruud T, Reas D. Distriktspsykiatriske sentre, tjenestetilbud og brukertilfredshet: Status og variasjon 2002, STF78 A035008. SINTEF Unimed; 2003.
   Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.
   PubMed Web of Science ®Google Scholar
• Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 1973;33:613–19.
   Web of Science ®Google Scholar
• SPSS (release 16.0) statistical software [computer program]. Chicago, IL: SPSS Inc.; 2009.
   Google Scholar
• Lilleeng S. Pasienter med rusmiddelbruk og samtidige psykiske lidelser i psykisk helsevern for voksne. Rapport. SINTEF A1159; 2007.
   Google Scholar
• Shear MK, Greeno C, Kang J, Ludewig D, Frank E, Swartz HA, . Diagnosis of nonpsychotic patients in community clinics. Am J Psychiatry 2000;157:581–7.
   PubMed Web of Science ®Google Scholar
• Ramirez BM, Bostic JQ, Davies D, Rush AJ, Witte B, Hendrickse W, . Methods to improve diagnostic accuracy in a community mental health setting. Am J Psychiatry 2000; 157:1599–605.
   Google Scholar
• Ananth J, Vandewater S, Kamal M, Brodsky A. Missed diagnosis of substance abuse in psychiatric patients. Hospital & Community Psychiatry 1989;40:297–9.
   PubMedGoogle Scholar
• Wing JK, Curtis RH, Beevor AS. HoNOS. Health of the Nation Outcome Scales. Report on Research and Development July 1993–December 1995. London: College Research Unit, Royal College of Psychiatrists; 1996.
   Google Scholar
• Mapstone J, Elbourne D, Roberts IG. Strategies to improve recruitment to research studies. Cochrane Database of Systematic Reviews 2007(2).
   Google Scholar
• Rendell JM, Merritt RK, Geddes JR. Incentives and disincentives to participation by clinicians in randomised controlled trials. Cochrane Database of Systematic Reviews 2007(2).
   Google Scholar
• Tyrer P, Al Muderis O, Gulbrandsen D. Distribution of case-load in community mental health teams [References]. Psychiat Bull 2001;25:10–2.
   Google Scholar
• Larun L, Helseth V, Bramness JG, Gråwe RW, Haugerud H, Høie B, . Dobbeldiagnose—alvorlig psykisk lidelse og ruslidelse Del 1 Screening og diagnoseinstrumenter. Oslo: Nasjonalt kunnskapssenter for helsetjenesten; 2007.
   Google Scholar
• Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II. Addiction 1993;88:791–804.
   PubMed Web of Science ®Google Scholar
• Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984;252:1905–7.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): Reliability for substance abusers. Am J Psychiatry 1996;153:1195–201.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHOs Composite International Diagnostic Interview. http://www.hcp.med.harvard.edu/wmhcidi/about.php.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J, Weiller E, Keskiner A, . The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232–41.
   Web of Science ®Google Scholar
• Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Sheehan KH, . The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. Eur Psychiatry 1997;12: 224–31.
   Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, research version, patient edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
   Google Scholar
• Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 2005;11:22–31.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980; 168:26–33.
   PubMed Web of Science ®Google Scholar
• Holsten F, Waal H. The DTES—Drug Taking Evaluation Scale: A simple scale for the evaluation of drug taking behaviour. Acta Psychiatr Scand 1980;61:275–305.
   PubMed Web of Science ®Google Scholar
• Pedersen K, Sandvik L, Waal H. Evaluation of DTES—A simple drug-taking scale. Addiction Res Theory 2007;15:637–49.
   Web of Science ®Google Scholar